Dr. Shafeeq Ladha from Barrow Neurological Institute will review a clinical trial of Actemra in ALS patients. The rationale for using the drug and the role of inflammation in ALS progression will be discussed.
Dr. Shafeeq Ladha from Barrow Neurological Institute will review a clinical trial of Actemra in ALS patients. The rationale for using the drug and the role of inflammation in ALS progression will be discussed.